Myriad Genetics (MYGN) Financial Statements & Analysis

Myriad Genetics (MYGN) Income Statement

Myriad Genetics reported revenue of $824.50M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 1.6% from $837.60M a year earlier. Myriad Genetics posted a net loss of $365.90M, compared with a net loss of $127.30M a year earlier. Gross margin was 69.9% and operating margin -8.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $190.70M, down 10.5% from the same quarter a year earlier.

Myriad Genetics Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Myriad Genetics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Jun 2020	Jun 2019	Jun 2018
Revenue & Gross Profit
Revenue	824.50	837.60	753.20	678.40	690.60	557.00	638.60	851.10
Cost of Revenue	247.90	252.20	236.20	202.00	197.60	178.20	186.10	201.00
Gross Profit	576.60	585.40	517.00	476.40	493.00	378.80	452.50	650.10
Operating Expenses
Research & Development	106.80	113.40	88.70	85.40	81.90	80.90	77.20	85.90
Selling, General & Administrative	537.60	560.00	572.90	514.70	537.80	500.70	507.30	556.60
Operating Expenses	644.40	708.90	774.40	600.10	683.50	653.30	684.20	642.50
Operating Income	-67.80	-123.50	-257.40	-123.70	-190.50	-194.80	-231.70	7.60
Other Income/Expense
Interest Income	1.80	1.70	2.50	2.60	0.70	9.20	3.00	3.20
Interest Expense	10.50	-2.80	-2.90	3.20	6.60	0.00	10.80	12.00
Other Income/Expense	-318.60	-5.00	-4.80	-16.90	133.40	-88.90	8.40	-7.60
Income
Income Before Tax	-395.10	-123.50	-262.20	-140.60	-57.10	-283.70	-223.30	0.00
Income Tax Expense	-29.20	3.80	1.10	-28.60	-29.90	-59.90	-23.70	-4.40
Net Income	-365.90	-127.30	-263.30	-112.00	-27.20	-223.70	-199.50	4.60
Net Income - Continuous Operations	-365.90	-127.30	-263.30	-112.00	-27.20	-223.70	-199.50	4.60
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-
EBITDA	-330.90	-26.80	-82.70	-84.70	12.30	-123.40	-140.50	85.00
EBIT	-384.60	-88.00	-144.60	-123.70	-50.50	-	-	-
Depreciation & Amortization	53.70	61.20	56.20	52.70	62.80	71.40	72.00	73.00
Earnings Per Share
Basic EPS	-4.00	-1.00	-3.00	-1.00	-	-3.00	-3.00	-
Diluted EPS	-4.00	-1.00	-3.00	-1.00	-	-3.00	-3.00	-
Basic Shares Outstanding	92.60	90.60	82.80	80.60	77.71	74.70	74.30	73.50
Diluted Shares Outstanding	92.60	90.60	82.80	80.60	78.00	74.78	74.30	76.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Myriad Genetics Financial Statements

What was Myriad Genetics's revenue in fiscal 2025?

Myriad Genetics reported revenue of $824.50M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 1.6% from $837.60M a year earlier.

Is Myriad Genetics profitable?

No. Myriad Genetics reported a net loss of $365.90M in fiscal 2025. In fiscal 2024 it lost $127.30M.

What is Myriad Genetics's operating margin?

Myriad Genetics's operating income was −$67.80M on revenue of $824.50M in fiscal 2025, an operating margin of -8.2%, compared with -14.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition